Table 6.
|
All |
ART (−) patients |
ART (+) patients |
|
|
|||
---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | P values | ||
Total* |
225 |
100.0% |
136 |
100.0% |
66 |
100.0% |
|
|
Malignant lymphoma |
50 |
22.2% |
33 |
24.3% |
16 |
24.2% |
0.997 |
|
Cytomegalovirus |
44 |
19.6% |
27 |
19.9% |
9 |
13.6% |
0.279 |
|
Pneumonia |
31 |
13.8% |
19 |
14.0% |
9 |
13.6% |
0.949 |
|
Pneumocystis jirovecii pneumonia |
30 |
13.3% |
21 |
15.4% |
4 |
6.1% |
0.058 |
|
Non-tuberculous mycobacterium |
12 |
5.3% |
10 |
7.4% |
2 |
3.0% |
0.367 |
Y |
Kaposi sarcoma |
11 |
4.9% |
7 |
5.1% |
2 |
3.0% |
0.749 |
Y |
Progressive multifocal leukoencephalopathy |
8 |
3.6% |
4 |
2.9% |
2 |
3.0% |
0.684 |
Y |
Cancer |
8 |
3.6% |
2 |
1.5% |
6 |
9.1% |
0.026 |
Y |
Hepatitis |
8 |
3.6% |
3 |
2.2% |
4 |
6.1% |
0.320 |
Y |
Cryptococcus |
7 |
3.1% |
6 |
4.4% |
0 |
0.0% |
0.197 |
Y |
Kidney failure |
7 |
3.1% |
4 |
2.9% |
3 |
4.5% |
0.861 |
Y |
HIV encephalopathy |
7 |
3.1% |
5 |
3.7% |
2 |
3.0% |
0.861 |
Y |
Aspergillus |
6 |
2.7% |
5 |
3.7% |
0 |
0.0% |
0.274 |
Y |
Toxoplasmosis |
4 |
1.8% |
3 |
2.2% |
1 |
1.5% |
0.835 |
Y |
Tuberculosis |
3 |
0.9% |
2 |
1.5% |
0 |
0.0% |
0.816 |
Y |
Sepsis |
3 |
1.3% |
2 |
1.5% |
1 |
1.5% |
0.551 |
Y |
Candida |
3 |
1.3% |
2 |
1.5% |
0 |
0.0% |
0.816 |
Y |
Varicella zoster virus |
2 |
1.3% |
1 |
0.7% |
1 |
1.5% |
0.816 |
Y |
Nocardia |
1 |
0.4% |
1 |
0.7% |
0 |
0.0% |
0.711 |
Y |
Histoplasma | 1 | 0.4% | 1 | 0.7% | 0 | 0.0% | 0.711 | Y |
*Because more than one illness was detected in patients, the numbers of all illness are greater than the total number.
HIV, human immunodeficiency virus. P values were calculated with the Chi-square test. Y indicates the use of Chi-square test with Yates correction. Bold font indicates statistical significance.